Loading clinical trials...

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD) | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT02191917

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)

Study 701-201 is a study in patients with late-onset Pompe disease (LOPD). The study will test respiratory muscle strength initially and again after 24 weeks in subjects treated or not treated with BM...

Lead sponsor: BioMarin Pharmaceutical•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATED

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

NCT03347253 · Late-onset Pompe Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2023Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment8

Start dateOct 2014

Last updatedJan 9, 2023

Condition

Late-onset Pompe Disease

Locations shown

University of Florida

Gainesville, Florida

Royal Brompton Hospital

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions